FIGS, Inc.

FIGS trades at a staggering 74.8 P/E despite sitting just 52.8 on the RSI—neither overbought nor oversold technically, yet fundamentally expensive relative to the broader apparel sector. The 13.28% short interest suggests meaningful skepticism about valuation sustainability. At $2.6B market cap, this medical apparel specialist commands premium multiples typically reserved for high-growth SaaS companies, not consumer cyclicals. The positioning feels precarious: not at 52-week highs despite the elevated multiple, indicating recent momentum has stalled while valuation hasn't compressed accordingly. This setup screams mean-reversion risk—shorts are positioned for exactly this kind of correction, making any weakness potentially violent in either direction.